Christopher Ehrlich

Christopher Ehrlich

Director/Board Member at EFFECTOR THERAPEUTICS, INC.

Net worth: 2 M $ as of 31/03/2024

54 year
Health Technology
Finance
Consumer Services

Profile

Christopher B.
Ehrlich
is the founder of Prostate Management Diagnostics, Inc. (founded in 2014) and holds the title of Director.
He is also the founder of AlgoRx Pharmaceuticals, Inc. Mr. Ehrlich's current jobs include being a Director at QuatRx Pharmaceuticals Co. (since 2004), Prolynx LLC (since 2022), and eFFECTOR Therapeutics, Inc. (since 2021).
He is also the Chief Operating Officer & Director at CERo Therapeutics Holdings, Inc. (since 2021).
Mr. Ehrlich's former jobs include being the Chief Executive Officer & Director at Locust Walk Acquisition Corp.
(2020-2021), Chief Executive Officer & Director at Phoenix Biotech Acquisition Corp., Director-Business Development at Genentech, Inc. (1997), Director at KAI Pharmaceuticals, Inc., Director at BioMimetic Therapeutics, Inc. (2004-2013), Director at Satori Pharmaceuticals, Inc., Director at Carbylan Therapeutics, Inc., Director at Invuity, Inc., Director at Solace Pharmaceuticals, Inc., Director at Xenon Pharmaceuticals, Inc., Director-Licensing & Business Development at Purdue Pharma LP (1998-1999), Director-Biotechnology Strategy Development at The Lek (1992-1994), Managing Director & General Partner at InterWest Partners LLC (2000-2013), Director at CVRx, Inc., Director-Venture Capital at The US Russia Investment Fund (1994-1996), and Director at Follica, Inc. He was also an Independent Director at Transcept Pharma, Inc. (2009-2013) and Senior MD & Head-Global Biopharma at Locust Walk Partners LLC (2013-2021).
Mr. Ehrlich's education includes an undergraduate degree from Dartmouth College (1992) and an MBA from Kellogg School of Management (1998).
Mr. Ehrlich is also the founder of AlgoRx Pharmaceuticals, Inc...

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
3.24%
05/04/2024 482,425 ( 3.24% ) 1 M $ 31/03/2024
29/02/2024 1,409 ( 0.04% ) 20 276 $ 31/03/2024

Christopher Ehrlich active positions

CompaniesPositionStart
EFFECTOR THERAPEUTICS, INC. Director/Board Member 25/08/2021
Director/Board Member 20/09/2022
Founder 01/01/2014
Director/Board Member 01/10/2004
All active positions of Christopher Ehrlich

Former positions of Christopher Ehrlich

CompaniesPositionEnd
EFFECTOR THERAPEUTICS, INC. Chief Executive Officer 01/08/2021
Corporate Officer/Principal 01/01/2021
INVUITY INC Director/Board Member 01/01/2018
Director/Board Member 31/12/2013
Corporate Officer/Principal 01/01/2013
See the detail of Christopher Ehrlich's experience

Training of Christopher Ehrlich

Dartmouth College Undergraduate Degree
Kellogg School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Ehrlich's experience

Connections

99

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
XENON PHARMACEUTICALS INC.

Health Technology

CVRX, INC.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Private companies20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Ehrlich